Global Active Pharmaceutical Ingredients CDMO Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 242866
  • calendar_today Published On: Dec, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Active Pharmaceutical Ingredients CDMO market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Active Pharmaceutical Ingredients CDMO size is estimated to be USD million in 2026 from USD million in 2020, with a change % between 2020 and 2021. The global Active Pharmaceutical Ingredients CDMO market size is expected to grow at a CAGR of % for the next five years.

Market segmentation

Active Pharmaceutical Ingredients CDMO market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Traditional Active Pharmaceutical Ingredient (Traditional API)

Highly Potent Active Pharmaceutical Ingredient (HP-API)

Antibody Drug Conjugate (ADC)

Others

Market segment by Application, can be divided into

Oncology

Hormonal

Glaucoma

Cardiovascular

Diabetes

Others

Market segment by players, this report covers

Cambrex

Recipharm

Thermo Fisher Pantheon

Corden Pharma

Samsung Biologics

Lonza

Catalent

Siegfried

Piramal Pharma Solutions

Boehringer Ingelheim

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Active Pharmaceutical Ingredients CDMO product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Active Pharmaceutical Ingredients CDMO, with revenue, gross margin and global market share of Active Pharmaceutical Ingredients CDMO from 2019 to 2021.

Chapter 3, the Active Pharmaceutical Ingredients CDMO competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Active Pharmaceutical Ingredients CDMO market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Active Pharmaceutical Ingredients CDMO research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Active Pharmaceutical Ingredients CDMO

1.2 Classification of Active Pharmaceutical Ingredients CDMO by Type

1.2.1 Overview: Global Active Pharmaceutical Ingredients CDMO Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Type in 2020

1.2.3 Traditional Active Pharmaceutical Ingredient (Traditional API)

1.2.4 Highly Potent Active Pharmaceutical Ingredient (HP-API)

1.2.5 Antibody Drug Conjugate (ADC)

1.2.6 Others

1.3 Global Active Pharmaceutical Ingredients CDMO Market by Application

1.3.1 Overview: Global Active Pharmaceutical Ingredients CDMO Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Oncology

1.3.3 Hormonal

1.3.4 Glaucoma

1.3.5 Cardiovascular

1.3.6 Diabetes

1.3.7 Others

1.4 Global Active Pharmaceutical Ingredients CDMO Market Size & Forecast

1.5 Global Active Pharmaceutical Ingredients CDMO Market Size and Forecast by Region

1.5.1 Global Active Pharmaceutical Ingredients CDMO Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Active Pharmaceutical Ingredients CDMO Market Size by Region, (2016-2021)

1.5.3 North America Active Pharmaceutical Ingredients CDMO Market Size and Prospect (2016-2026)

1.5.4 Europe Active Pharmaceutical Ingredients CDMO Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size and Prospect (2016-2026)

1.5.6 South America Active Pharmaceutical Ingredients CDMO Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Active Pharmaceutical Ingredients CDMO Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Active Pharmaceutical Ingredients CDMO Market Drivers

1.6.2 Active Pharmaceutical Ingredients CDMO Market Restraints

1.6.3 Active Pharmaceutical Ingredients CDMO Trends Analysis

2 Company Profiles

2.1 Cambrex

2.1.1 Cambrex Details

2.1.2 Cambrex Major Business

2.1.3 Cambrex Active Pharmaceutical Ingredients CDMO Product and Solutions

2.1.4 Cambrex Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 Cambrex Recent Developments and Future Plans

2.2 Recipharm

2.2.1 Recipharm Details

2.2.2 Recipharm Major Business

2.2.3 Recipharm Active Pharmaceutical Ingredients CDMO Product and Solutions

2.2.4 Recipharm Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 Recipharm Recent Developments and Future Plans

2.3 Thermo Fisher Pantheon

2.3.1 Thermo Fisher Pantheon Details

2.3.2 Thermo Fisher Pantheon Major Business

2.3.3 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product and Solutions

2.3.4 Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Thermo Fisher Pantheon Recent Developments and Future Plans

2.4 Corden Pharma

2.4.1 Corden Pharma Details

2.4.2 Corden Pharma Major Business

2.4.3 Corden Pharma Active Pharmaceutical Ingredients CDMO Product and Solutions

2.4.4 Corden Pharma Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Corden Pharma Recent Developments and Future Plans

2.5 Samsung Biologics

2.5.1 Samsung Biologics Details

2.5.2 Samsung Biologics Major Business

2.5.3 Samsung Biologics Active Pharmaceutical Ingredients CDMO Product and Solutions

2.5.4 Samsung Biologics Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Samsung Biologics Recent Developments and Future Plans

2.6 Lonza

2.6.1 Lonza Details

2.6.2 Lonza Major Business

2.6.3 Lonza Active Pharmaceutical Ingredients CDMO Product and Solutions

2.6.4 Lonza Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Lonza Recent Developments and Future Plans

2.7 Catalent

2.7.1 Catalent Details

2.7.2 Catalent Major Business

2.7.3 Catalent Active Pharmaceutical Ingredients CDMO Product and Solutions

2.7.4 Catalent Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Catalent Recent Developments and Future Plans

2.8 Siegfried

2.8.1 Siegfried Details

2.8.2 Siegfried Major Business

2.8.3 Siegfried Active Pharmaceutical Ingredients CDMO Product and Solutions

2.8.4 Siegfried Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Siegfried Recent Developments and Future Plans

2.9 Piramal Pharma Solutions

2.9.1 Piramal Pharma Solutions Details

2.9.2 Piramal Pharma Solutions Major Business

2.9.3 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product and Solutions

2.9.4 Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Piramal Pharma Solutions Recent Developments and Future Plans

2.10 Boehringer Ingelheim

2.10.1 Boehringer Ingelheim Details

2.10.2 Boehringer Ingelheim Major Business

2.10.3 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product and Solutions

2.10.4 Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 Boehringer Ingelheim Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Active Pharmaceutical Ingredients CDMO Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Active Pharmaceutical Ingredients CDMO Players Market Share

3.2.2 Top 10 Active Pharmaceutical Ingredients CDMO Players Market Share

3.2.3 Market Competition Trend

3.3 Active Pharmaceutical Ingredients CDMO Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Active Pharmaceutical Ingredients CDMO Revenue and Market Share by Type (2016-2021)

4.2 Global Active Pharmaceutical Ingredients CDMO Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Application (2016-2021)

5.2 Active Pharmaceutical Ingredients CDMO Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Active Pharmaceutical Ingredients CDMO Revenue by Type (2016-2026)

6.2 North America Active Pharmaceutical Ingredients CDMO Revenue by Application (2016-2026)

6.3 North America Active Pharmaceutical Ingredients CDMO Market Size by Country

6.3.1 North America Active Pharmaceutical Ingredients CDMO Revenue by Country (2016-2026)

6.3.2 United States Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

6.3.3 Canada Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

6.3.4 Mexico Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Active Pharmaceutical Ingredients CDMO Revenue by Type (2016-2026)

7.2 Europe Active Pharmaceutical Ingredients CDMO Revenue by Application (2016-2026)

7.3 Europe Active Pharmaceutical Ingredients CDMO Market Size by Country

7.3.1 Europe Active Pharmaceutical Ingredients CDMO Revenue by Country (2016-2026)

7.3.2 Germany Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

7.3.3 France Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

7.3.5 Russia Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

7.3.6 Italy Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Active Pharmaceutical Ingredients CDMO Revenue by Type (2016-2026)

8.2 Asia-Pacific Active Pharmaceutical Ingredients CDMO Revenue by Application (2016-2026)

8.3 Asia-Pacific Active Pharmaceutical Ingredients CDMO Market Size by Region

8.3.1 Asia-Pacific Active Pharmaceutical Ingredients CDMO Revenue by Region (2016-2026)

8.3.2 China Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

8.3.3 Japan Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

8.3.4 South Korea Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

8.3.5 India Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

8.3.7 Australia Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Active Pharmaceutical Ingredients CDMO Revenue by Type (2016-2026)

9.2 South America Active Pharmaceutical Ingredients CDMO Revenue by Application (2016-2026)

9.3 South America Active Pharmaceutical Ingredients CDMO Market Size by Country

9.3.1 South America Active Pharmaceutical Ingredients CDMO Revenue by Country (2016-2026)

9.3.2 Brazil Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

9.3.3 Argentina Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Active Pharmaceutical Ingredients CDMO Revenue by Type (2016-2026)

10.2 Middle East & Africa Active Pharmaceutical Ingredients CDMO Revenue by Application (2016-2026)

10.3 Middle East & Africa Active Pharmaceutical Ingredients CDMO Market Size by Country

10.3.1 Middle East & Africa Active Pharmaceutical Ingredients CDMO Revenue by Country (2016-2026)

10.3.2 Turkey Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

10.3.4 UAE Active Pharmaceutical Ingredients CDMO Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Active Pharmaceutical Ingredients CDMO Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Active Pharmaceutical Ingredients CDMO Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Active Pharmaceutical Ingredients CDMO Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Active Pharmaceutical Ingredients CDMO Revenue (USD Million) by Region (2016-2021)

Table 5. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Region (2021-2026)

Table 6. Cambrex Corporate Information, Head Office, and Major Competitors

Table 7. Cambrex Major Business

Table 8. Cambrex Active Pharmaceutical Ingredients CDMO Product and Solutions

Table 9. Cambrex Active Pharmaceutical Ingredients CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. Recipharm Corporate Information, Head Office, and Major Competitors

Table 11. Recipharm Major Business

Table 12. Recipharm Active Pharmaceutical Ingredients CDMO Product and Solutions

Table 13. Recipharm Active Pharmaceutical Ingredients CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Thermo Fisher Pantheon Corporate Information, Head Office, and Major Competitors

Table 15. Thermo Fisher Pantheon Major Business

Table 16. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Product and Solutions

Table 17. Thermo Fisher Pantheon Active Pharmaceutical Ingredients CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Corden Pharma Corporate Information, Head Office, and Major Competitors

Table 19. Corden Pharma Major Business

Table 20. Corden Pharma Active Pharmaceutical Ingredients CDMO Product and Solutions

Table 21. Corden Pharma Active Pharmaceutical Ingredients CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Samsung Biologics Corporate Information, Head Office, and Major Competitors

Table 23. Samsung Biologics Major Business

Table 24. Samsung Biologics Active Pharmaceutical Ingredients CDMO Product and Solutions

Table 25. Samsung Biologics Active Pharmaceutical Ingredients CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Lonza Corporate Information, Head Office, and Major Competitors

Table 27. Lonza Major Business

Table 28. Lonza Active Pharmaceutical Ingredients CDMO Product and Solutions

Table 29. Lonza Active Pharmaceutical Ingredients CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Catalent Corporate Information, Head Office, and Major Competitors

Table 31. Catalent Major Business

Table 32. Catalent Active Pharmaceutical Ingredients CDMO Product and Solutions

Table 33. Catalent Active Pharmaceutical Ingredients CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Siegfried Corporate Information, Head Office, and Major Competitors

Table 35. Siegfried Major Business

Table 36. Siegfried Active Pharmaceutical Ingredients CDMO Product and Solutions

Table 37. Siegfried Active Pharmaceutical Ingredients CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Piramal Pharma Solutions Corporate Information, Head Office, and Major Competitors

Table 39. Piramal Pharma Solutions Major Business

Table 40. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Product and Solutions

Table 41. Piramal Pharma Solutions Active Pharmaceutical Ingredients CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. Boehringer Ingelheim Corporate Information, Head Office, and Major Competitors

Table 43. Boehringer Ingelheim Major Business

Table 44. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Product and Solutions

Table 45. Boehringer Ingelheim Active Pharmaceutical Ingredients CDMO Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Global Active Pharmaceutical Ingredients CDMO Revenue (USD Million) by Players (2019-2021)

Table 47. Global Active Pharmaceutical Ingredients CDMO Revenue Share by Players (2019-2021)

Table 48. Breakdown of Active Pharmaceutical Ingredients CDMO by Company Type (Tier 1, Tier 2 and Tier 3)

Table 49. Active Pharmaceutical Ingredients CDMO Players Head Office, Products and Services Provided

Table 50. Active Pharmaceutical Ingredients CDMO Mergers & Acquisitions in the Past Five Years

Table 51. Active Pharmaceutical Ingredients CDMO New Entrants and Expansion Plans

Table 52. Global Active Pharmaceutical Ingredients CDMO Revenue (USD Million) by Type (2016-2021)

Table 53. Global Active Pharmaceutical Ingredients CDMO Revenue Share by Type (2016-2021)

Table 54. Global Active Pharmaceutical Ingredients CDMO Revenue Forecast by Type (2021-2026)

Table 55. Global Active Pharmaceutical Ingredients CDMO Revenue by Application (2016-2021)

Table 56. Global Active Pharmaceutical Ingredients CDMO Revenue Forecast by Application (2021-2026)

Table 57. North America Active Pharmaceutical Ingredients CDMO Revenue by Type (2016-2021) & (USD Million)

Table 58. North America Active Pharmaceutical Ingredients CDMO Revenue by Type (2021-2026) & (USD Million)

Table 59. North America Active Pharmaceutical Ingredients CDMO Revenue by Application (2016-2021) & (USD Million)

Table 60. North America Active Pharmaceutical Ingredients CDMO Revenue by Application (2021-2026) & (USD Million)

Table 61. North America Active Pharmaceutical Ingredients CDMO Revenue by Country (2016-2021) & (USD Million)

Table 62. North America Active Pharmaceutical Ingredients CDMO Revenue by Country (2021-2026) & (USD Million)

Table 63. Europe Active Pharmaceutical Ingredients CDMO Revenue by Type (2016-2021) & (USD Million)

Table 64. Europe Active Pharmaceutical Ingredients CDMO Revenue by Type (2021-2026) & (USD Million)

Table 65. Europe Active Pharmaceutical Ingredients CDMO Revenue by Application (2016-2021) & (USD Million)

Table 66. Europe Active Pharmaceutical Ingredients CDMO Revenue by Application (2021-2026) & (USD Million)

Table 67. Europe Active Pharmaceutical Ingredients CDMO Revenue by Country (2016-2021) & (USD Million)

Table 68. Europe Active Pharmaceutical Ingredients CDMO Revenue by Country (2021-2026) & (USD Million)

Table 69. Asia-Pacific Active Pharmaceutical Ingredients CDMO Revenue by Type (2016-2021) & (USD Million)

Table 70. Asia-Pacific Active Pharmaceutical Ingredients CDMO Revenue by Type (2021-2026) & (USD Million)

Table 71. Asia-Pacific Active Pharmaceutical Ingredients CDMO Revenue by Application (2016-2021) & (USD Million)

Table 72. Asia-Pacific Active Pharmaceutical Ingredients CDMO Revenue by Application (2021-2026) & (USD Million)

Table 73. Asia-Pacific Active Pharmaceutical Ingredients CDMO Revenue by Region (2016-2021) & (USD Million)

Table 74. Asia-Pacific Active Pharmaceutical Ingredients CDMO Revenue by Region (2021-2026) & (USD Million)

Table 75. South America Active Pharmaceutical Ingredients CDMO Revenue by Type (2016-2021) & (USD Million)

Table 76. South America Active Pharmaceutical Ingredients CDMO Revenue by Type (2021-2026) & (USD Million)

Table 77. South America Active Pharmaceutical Ingredients CDMO Revenue by Application (2016-2021) & (USD Million)

Table 78. South America Active Pharmaceutical Ingredients CDMO Revenue by Application (2021-2026) & (USD Million)

Table 79. South America Active Pharmaceutical Ingredients CDMO Revenue by Country (2016-2021) & (USD Million)

Table 80. South America Active Pharmaceutical Ingredients CDMO Revenue by Country (2021-2026) & (USD Million)

Table 81. Middle East & Africa Active Pharmaceutical Ingredients CDMO Revenue by Type (2016-2021) & (USD Million)

Table 82. Middle East & Africa Active Pharmaceutical Ingredients CDMO Revenue by Type (2021-2026) & (USD Million)

Table 83. Middle East & Africa Active Pharmaceutical Ingredients CDMO Revenue by Application (2016-2021) & (USD Million)

Table 84. Middle East & Africa Active Pharmaceutical Ingredients CDMO Revenue by Application (2021-2026) & (USD Million)

Table 85. Middle East & Africa Active Pharmaceutical Ingredients CDMO Revenue by Country (2016-2021) & (USD Million)

Table 86. Middle East & Africa Active Pharmaceutical Ingredients CDMO Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Active Pharmaceutical Ingredients CDMO Picture

Figure 2. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Type in 2020

Figure 3. Traditional Active Pharmaceutical Ingredient (Traditional API)

Figure 4. Highly Potent Active Pharmaceutical Ingredient (HP-API)

Figure 5. Antibody Drug Conjugate (ADC)

Figure 6. Others

Figure 7. Active Pharmaceutical Ingredients CDMO Revenue Market Share by Application in 2020

Figure 8. Oncology Picture

Figure 9. Hormonal Picture

Figure 10. Glaucoma Picture

Figure 11. Cardiovascular Picture

Figure 12. Diabetes Picture

Figure 13. Others Picture

Figure 14. Global Active Pharmaceutical Ingredients CDMO Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 15. Global Active Pharmaceutical Ingredients CDMO Revenue and Forecast (2016-2026) & (USD Million)

Figure 16. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Region (2016-2026)

Figure 17. Global Active Pharmaceutical Ingredients CDMO Revenue Market Share by Region in 2020

Figure 18. North America Active Pharmaceutical Ingredients CDMO Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Europe Active Pharmaceutical Ingredients CDMO Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. Asia-Pacific Active Pharmaceutical Ingredients CDMO Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. South America Active Pharmaceutical Ingredients CDMO Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Middle East and Africa Active Pharmaceutical Ingredients CDMO Revenue (USD Million) and Growth Rate (2016-2026)

Figure 23. Active Pharmaceutical Ingredients CDMO Market Drivers

Figure 24. Active Pharmaceutical Ingredients CDMO Market Restraints

Figure 25. Active Pharmaceutical Ingredients CDMO Market Trends

Figure 26. Cambrex Recent Developments and Future Plans

Figure 27. Recipharm Recent Developments and Future Plans

Figure 28. Thermo Fisher Pantheon Recent Developments and Future Plans

Figure 29. Corden Pharma Recent Developments and Future Plans

Figure 30. Samsung Biologics Recent Developments and Future Plans

Figure 31. Lonza Recent Developments and Future Plans

Figure 32. Catalent Recent Developments and Future Plans

Figure 33. Siegfried Recent Developments and Future Plans

Figure 34. Piramal Pharma Solutions Recent Developments and Future Plans

Figure 35. Boehringer Ingelheim Recent Developments and Future Plans

Figure 36. Global Active Pharmaceutical Ingredients CDMO Revenue Share by Players in 2020

Figure 37. Active Pharmaceutical Ingredients CDMO Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 38. Global Top 3 Players Active Pharmaceutical Ingredients CDMO Revenue Market Share in 2020

Figure 39. Global Top 10 Players Active Pharmaceutical Ingredients CDMO Revenue Market Share in 2020

Figure 40. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 41. Global Active Pharmaceutical Ingredients CDMO Revenue Share by Type in 2020

Figure 42. Global Active Pharmaceutical Ingredients CDMO Market Share Forecast by Type (2021-2026)

Figure 43. Global Active Pharmaceutical Ingredients CDMO Revenue Share by Application in 2020

Figure 44. Global Active Pharmaceutical Ingredients CDMO Market Share Forecast by Application (2021-2026)

Figure 45. North America Active Pharmaceutical Ingredients CDMO Sales Market Share by Type (2016-2026)

Figure 46. North America Active Pharmaceutical Ingredients CDMO Sales Market Share by Application (2016-2026)

Figure 47. North America Active Pharmaceutical Ingredients CDMO Revenue Market Share by Country (2016-2026)

Figure 48. United States Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 49. Canada Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 50. Mexico Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 51. Europe Active Pharmaceutical Ingredients CDMO Sales Market Share by Type (2016-2026)

Figure 52. Europe Active Pharmaceutical Ingredients CDMO Sales Market Share by Application (2016-2026)

Figure 53. Europe Active Pharmaceutical Ingredients CDMO Revenue Market Share by Country (2016-2026)

Figure 54. Germany Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 55. France Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. United Kingdom Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Russia Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Italy Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 59. Asia-Pacific Active Pharmaceutical Ingredients CDMO Sales Market Share by Type (2016-2026)

Figure 60. Asia-Pacific Active Pharmaceutical Ingredients CDMO Sales Market Share by Application (2016-2026)

Figure 61. Asia-Pacific Active Pharmaceutical Ingredients CDMO Revenue Market Share by Region (2016-2026)

Figure 62. China Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. Japan Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. South Korea Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. India Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Southeast Asia Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 67. Australia Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 68. South America Active Pharmaceutical Ingredients CDMO Sales Market Share by Type (2016-2026)

Figure 69. South America Active Pharmaceutical Ingredients CDMO Sales Market Share by Application (2016-2026)

Figure 70. South America Active Pharmaceutical Ingredients CDMO Revenue Market Share by Country (2016-2026)

Figure 71. Brazil Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. Argentina Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Middle East and Africa Active Pharmaceutical Ingredients CDMO Sales Market Share by Type (2016-2026)

Figure 74. Middle East and Africa Active Pharmaceutical Ingredients CDMO Sales Market Share by Application (2016-2026)

Figure 75. Middle East and Africa Active Pharmaceutical Ingredients CDMO Revenue Market Share by Country (2016-2026)

Figure 76. Turkey Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 77. Saudi Arabia Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 78. UAE Active Pharmaceutical Ingredients CDMO Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Methodology

Figure 80. Research Process and Data Source

shopping_cart License Type

Buy Now

email Quick Contact

tag_faces Our Clients

help Need Help?

Please contact directly on our US and India numbers

+1-201-465-4211

Please feel free to write an email to us or to use our electronic ticketing system.

sales@marketsandresearch.biz